Factors Associated With Infusion Reactions in Patients With Breast Cancer Receiving Trastuzumab
IR should be considered when PER is combined with TRA. ALP and HDL cholesterol levels may be predictive markers of TRA-induced IR in patients with breast cancer.
Authors
- Toshinobu Hayashi (ORCID: https://orcid.org/0000-0001-6183-4939)
- Koichi Matsuo (ORCID: https://orcid.org/0000-0002-1490-8955)
- Ryuji Yamaguchi (ORCID: https://orcid.org/0000-0002-1706-7063)
- Kohei Oyabu
- Motoyasu Miyazaki (ORCID: https://orcid.org/0000-0002-4526-3045)
- Takafumi Nakano (ORCID: https://orcid.org/0000-0003-4298-2041)
- Masanobu Uchiyama (ORCID: https://orcid.org/0000-0001-6385-5944)
Institutions
- Fukuoka University (JP)
- Fukuoka University Hospital (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2024-11-02
- DOI
- https://doi.org/10.21873/cdp.10387
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00